- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
PET/CT colonography could provide 'all-in-one' staging
Integrated fused imaging detects polyps found with optical colonoscopy as well as extracolonic tumors
Researchers have found success integrating whole-body PET/CT tumor, lymph node, and metastasis staging with CT colonography in one exam. The technique provided accurate results for TNM staging in patients with colorectal cancer.
The CT colonography adds only seven minutes to the exam, which might be shortened with newer protocols, according to Dr. Patrick Veit, a radiologist now at University Hospital Zurich in Switzerland.
Veit and former colleagues from University Hospital Essen in Germany presented a study of 14 patients at the 2006 European Congress of Radiology. A study with more patients is currently under review. Patients undergo whole-body PET/CT after water-based bowel distention and pharmacological bowel relaxation. Histopathology from conventional colonoscopy, as well as surgical histopathology, serves as the standard of reference. Radiologists use 3D primary reading for all exams.
In the study of 14 patients, PET/CT colonography revealed 18 of 19 colonic lesions detected by conventional colonoscopy; only one flat lesion was missed. Six extracolonic tumor sites were detected with the integrated PET/CT exam. Based on the imaging findings, 11 patients were treated surgically, while three received chemotherapy. For the surgically treated patients, PET/CT revealed correct T-stage in eight patients and correct N-stage in nine patients.
"Whole-body PET/CT with integrated CT colonography might be used as an all-in-one staging procedure, especially in patients with incomplete colonoscopy," Veit said.
A future endeavor would be trying new tracers, such as one that indicates hypoxia that could be used for neoadjuvant downstaging, he said.
Can Portable Dual-Energy X-Ray be a Viable Alternative to CT in the ICU?
September 13th 2024The use of a portable dual-energy X-ray detector in the ICU at one community hospital reportedly facilitated a 37.5 percent decrease in chest CT exams in comparison to the previous three months, according to research presented at the American Society of Emergency Radiology (ASER) meeting in Washington, D.C.
New Meta-Analysis Examines MRI Assessment for Treatment of Esophageal Cancer
September 12th 2024Diffusion-weighted MRI provided pooled sensitivity and specificity rates of 82 percent and 81 percent respectively for gauging patient response to concurrent chemoradiotherapy for esophageal cancer, according to new meta-analysis.
Study for Emerging PET/CT Agent Reveals ‘New Standard’ for Detecting Clear Cell Renal Cell Carcinoma
September 11th 2024Results from a multicenter phase 3 trial showed that the PET/CT imaging agent (89Zr)Zr-girentuximab had an 85.5 percent mean sensitivity rate for the diagnosis of clear cell renal cell carcinoma.
Can Radiomics and Autoencoders Enhance Real-Time Ultrasound Detection of Breast Cancer?
September 10th 2024Developed with breast ultrasound data from nearly 1,200 women, a model with mixed radiomic and autoencoder features had a 90 percent AUC for diagnosing breast cancer, according to new research.
